Global WholeHealth Partners’ (GWHP) primary focus is to lead the global fight against fatal infectious diseases through collaboration and extensive research and development. Our goal is to continue to support the availability of fast and accurate test results as they can prompt early treatment for patients and ultimately reduce the costs of healthcare around the world.
WHAT WE DO
GWHP is an international supplier of cutting-edge technologies that detect the presence of diseases ahead of our industry competitors. These technologies include In-vitro Diagnostic (IVD) Real-Time PCR Machines and Whole Blood/Serum/Plasma Rapid Diagnostic Tests (RDT). For example, instead of healthcare professionals and patients waiting 48-72 hours for results, our tests can provide answers within 90 minutes at the most, and some within less than 10 minutes.
GWHP is committed to building long-term shareholder value through the vertical integration of proven, well-established businesses that effectively and efficiently control the outbreak of diseases while significantly reducing healthcare costs.
Our vision is to heal the world by connecting healthcare professionals and patients to the best diagnostic technologies and to use our business to inspire and implement solutions for the worst threats to human life and healthcare.
Unlike many of our competitors, GWHP has partnered with several healthcare companies that work together in the process of identifying new viruses and creating specific diagnostic tests for them. This allows us to design new tests within 8-12 weeks for a fraction of the typical cost. For example, during the outbreak of the West African Ebola virus epidemic in 2014, we became the only company with Rapid Diagnostic Kits that test for Ebola. Soon afterwards, in 2016, we were able to create the only Rapid Diagnostic Kits for the Zika Virus. We are fully committed to continue to lead the global fight against fatal infectious diseases as they arise.
You can always read about our most current tests and products in our NEWSLETTER.